Serum Institute of India Announces COVID Vaccine Availability by the End of the Year

The Serum Institute of India in Pune reported the coronavirus vaccine would be available on the market by the end of this year. Furthermore, the firm will also disclose the vaccine price within two months. Let us know that Serum Institute is the world’s largest vaccine maker, and a vaccine called Covishield will be launched in India. The vaccine was developed by scientists at the University of Oxford and is being prepared by the Serum Institute and the company AstraZeneca Pharma (AstraZeneca).

Speaking to CNBC-TV18, Serum Institute of India CEO Adar Poonawala said, “We hope to have the coronavirus vaccine by the end of this year.”

He said we’ll reveal the price of this vaccine in two months ‘ time.

The vaccine will be produced by the end of August. He said we will be testing this vaccine along with ICMR on thousands of patients in India. Production of the vaccines will start by the end of August. I sincerely hope the vaccine trial succeeds. The company is launching the Coronavirus vaccine in India under the Covishield and Novavax names.

Bill and Melinda Gates Foundation Serum Institute of India to manufacture 100 million doses of Corona Virus Vaccine. He has also tied up with Gavi. The company can provide other poor and developing countries. It includes India, with a dose of Coronavirus vaccine for 225 rupees or $3. But, after two months, the final vaccine price will be calculated.

More than 200 initiatives in preparation of the coronavirus vaccine are underway these days. There are more than 21 of such vaccines in clinical trials. This vaccine is in the final human trial stage. If this study works then the corona vaccine will be available worldwide by 2021.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button